EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress and Lysosomal Dysfunction in Neurodegenerative Diseases: Underlying Mechanisms and Nanotherapeutic Targeting Strategies

Yuhe Hu, Zhaofei Yang, Xu Wang, Xiang Li, Min Wei iD

Antioxidants · 06.01.2026 · 15 (1) · 73

DOI: 10.3390/antiox15010073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 06.01.2026. Verfasst von Yuhe Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Project of Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases (NDDs), defined by the progressive loss of neurons, present a major challenge to global health. Oxidative stress and lysosomal dysfunction are both key pathogenic factors in NDDs, and they do not operate in isolation; instead, the vicious cycle they form, often mediated through organellar crosstalk, serves as the core driver of the pathological progression of NDDs, collectively worsening disease outcomes. Specifically, excessive reactive oxygen species (ROS) can disrupt lysosomal membrane integrity through lipid peroxidation and inhibit the activity of vacuolar ATPase (V-ATPase), ultimately leading to impaired lysosomal acidification. Meanwhile, lysosomal dysfunction hinders the clearance of damaged mitochondria (the primary endogenous source of ROS), toxic protein aggregates, and free iron ions. This further exacerbates ROS accumulation and accelerates neuronal degeneration. Conventional therapeutic approaches have limited efficacy, primarily due to the challenges in crossing the blood–brain barrier (BBB), insufficient targeting ability, and an inability to effectively intervene in this pathological loop. Nanotherapeutics, leveraging their tunable physicochemical properties and modular functional design, represent a transformative strategy to address these limitations. This review systematically elaborates on the reciprocal interplay between oxidative stress and lysosomal dysfunction in NDDs, with a particular focus on the central role of lysosome-mitochondria axis dysfunction, critically appraises recent advances in nanotechnology-based targeted therapies, and thereby provides a comprehensive theoretical framework to guide the development of novel NDD therapeutics.

Schlagwörter

Stichwörter der Autor:innen

lysosomal dysfunctionnanodrugsneurodegenerative diseasesoxidative stress

Autor:innen und Institutionen

  • Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.

ORCID-Profile: Min Wei

Förderung

  • The Project of Natural Science Foundation of Liaoning Province

Zitieren

APA

Hu, Y., Yang, Z., Wang, X., Li, X., & Wei, M. (2026). Oxidative Stress and Lysosomal Dysfunction in Neurodegenerative Diseases: Underlying Mechanisms and Nanotherapeutic Targeting Strategies. Antioxidants, 15(1), 73. https://doi.org/10.3390/antiox15010073

Vancouver

Hu Y, Yang Z, Wang X, Li X, Wei M. Oxidative Stress and Lysosomal Dysfunction in Neurodegenerative Diseases: Underlying Mechanisms and Nanotherapeutic Targeting Strategies. Antioxidants. 2026;15(1):73. doi:10.3390/antiox15010073

BibTeX
@article{Hu2026,
  author = {Hu, Yuhe and Yang, Zhaofei and Wang, Xu and Li, Xiang and Wei, Min},
  title = {Oxidative Stress and Lysosomal Dysfunction in Neurodegenerative Diseases: Underlying Mechanisms and Nanotherapeutic Targeting Strategies},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {73},
  doi = {10.3390/antiox15010073}
}
Kostenlos starten →